Event

HOT TOPIC Discussion: Viscoelastic Testing – Basics, Current Practice, and COVID-19 (21EL-610) – Free for AABB Individual Members!

Please note: AABB reserves the right to make updates to this program.

Live Program Date: Thursday, March 4, 2021 - On-Demand Available
Program Number: 21EL-610

Registration

This on-demand Hot Topic Discussion is provided complimentary to AABB individual members through the generous support of Haemonetics and Instrumentation Laboratory; nonmembers to pay regular eCast rate of $69. Group viewing/registration is not provided. After registering, access is granted via the AABB Education platform (after logging in using your AABB username and password simply click “My Learning Programs” and then “Hot Topic Discussions”). Please note: if you registered for the live program you do not need to register for this on-demand hot topic discussion (access to the on-demand hot topic discussion was included with the live program registration).

If you would like to receive this program for free as well as other great benefits consider joining AABB today.

  • Program Sponsors

    Haemonetics
    Instrumentation Laboratory

    Program Description

    Viscoelastic assays – Thromboelastometry (ROTEM) or Thromboelastography (TEG) – continue to be valuable for the assessment and management of major bleeding in trauma, cardiovascular surgery, post-partum hemorrhage and liver transplant. Heightened attention was brought to these tests when the FDA recently expanded their indications for use to include hospitalized patients suspected of a COVID-19 associated coagulopathy.

    Experts will first describe these assays, review the advantages and disadvantages compared to conventional coagulation tests, and explain how parameters can rapidly identify underlying coagulopathies and guide goal-directed blood component therapy. Next, the discussion will shift to the FDA guidance and the value of this technology in the assessment and management of hypercoagulability in COVID-19 patients.

    An extended Q&A period will follow presentations to give the audience an opportunity to join the discussion.

    Moderator: Karen Palmer, MT(ASCP), CQA(ASQ), AABB
    Speakers:

    • Melissa Cushing, MD, Weill Cornell Medicine
    • Hunter Moore, MD, PhD, University of Colorado
    • Karen Palmer, MT(ASCP), CQA(ASQ), AABB

    Learning Objectives

    After participating in this educational activity, participants should be able to:

    • Describe the basic principles and clinical utilization of viscoelastic testing in bleeding and thrombosis, including in the hypercoagulability in COVID-19 patients.
    • Explain the key parameters for both assays and how these parameters reflect the various aspects of clot formation.
    • Discuss potential institutional hurdles to the adoption of viscoelastic testing.
    • Interpret the recently issued FDA guidance that provides for the modified use of these devices to facilitate patient management during the COVID-19 public health emergency.

    Continuing Education Credit

    AABB designates both the live and on-demand version of this program each to be eligible for 1.25 continuing education credits/contact hours for California Nurse, California Lab Personnel, Florida Lab Personnel and General Participation credit. The final number of credit(s) and credit types awarded for this program (live or on-demand) was determined by the program duration. Please note this program is not eligible for continuing medical education (CME) credit for physicians. For more information on each credit type please visit our Continuing Education Credits webpage.

    Disclosures for the program faculty are provided at the beginning of the program.

    Register